🤗Meet Us at the 27th #IPOS World Congress!
Date🗓️: 9–12 Nov 2026
Location📍: Barcelona, Spain
Booth🪧: #1
More details🔗: www.mdpi.com/about/announ...
#CancersMDPI #MDPIconference #PsychoOncology #survivorship #PalliativeCare #DigitalHealth #CancerCare #IPOS2026 @ipospsychooncol.bsky.social
![Figure 2. KM Curves by SDH status, stratified by TOO and stage (8 panels). Footnote: Panels (A–D) depict overall survival among patients who achieved textbook oncological outcomes (TOO+) stratified by SDH status (favorable [+] vs. unfavorable [−] SDH) for Stage I (A), Stage II (B), Stage III (C), and Stage IVa (D) esophageal cancer.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:gtwq6vtyyymmu7vxtnu2ujmq/bafkreigekgahqhynapbcdhm634asw6bwxvrc56tm3i5glsbsnt7qssrx7m)
![Figure 1. Characterization of JsEV and curcumin-loaded JCsEV. (A) Particle size distribution and concentration profiles of JsEV and JCsEV determined by nanoparticle tracking analysis (NTA). Representative measurements demonstrate a predominant vesicle population within the expected size range of sEVs. (B) Representative transmission electron microscopy (TEM) images of JsEV and JCsEV showing typical cup-shaped vesicles with heterogeneous size distribution. Scale bars: 200 nm. (C) Western blot analysis of JsEV and JCsEV demonstrating the presence of canonical sEV markers (TSG101 and CD9) and the absence of the negative marker GRP94. Each lane was loaded with 5 µg protein. Curcumin loading was performed using a previously HPLC-validated protocol demonstrating a loading efficiency of 0.56 ± 0.01 µg curcumin per 1 µg albumin-EV [19].](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:gtwq6vtyyymmu7vxtnu2ujmq/bafkreidd6to3zoebrj54yzdocfx4ktwczgplhij4kh2ksnnzhq3qvvuvo4)
![Figure 1. Summit™ 2.0 workflow including the Chromosomal Arm-Level Aneuploidy [7] and the Belay Vantage assay [13] which have been previously validated. Summit™ 2.0 content showing the different variant types and biomarkers evaluated. SNVs, single nucleotide variants; MNVs, multi-nucleotide variants; Indels, insertions/deletions; CNVs, copy-number variants; TMB, tumor mutational burden; MSI, microsatellite instability.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:gtwq6vtyyymmu7vxtnu2ujmq/bafkreifvflhbhco466muryjzftfuly7mh427obuphm4tuvwy5qpq76pllu)
